Literature DB >> 30468816

Prevention of acetaminophen-induced liver injury by alginate.

Eyal Shteyer1, Ami Ben Ya'acov2, Lidia Zolotaryova1, Avital Sinai1, Mordechai Slae1, Smadar Cohen3, Yaron Ilan1.   

Abstract

INTRODUCTION: Acetaminophen (APAP) intoxication is a major cause of acute liver failure. Alginate, an anionic polysaccharide, was previously shown as a macroporous scaffold, to reduce liver inflammation and sustain hepatic synthetic function, when implanted on liver remnant after extended partial hepatectomy. In the recent study we wanted to examine in a model of APAP intoxication the potential of a specially formulated alginate solution to prevent APAP toxicity.
METHODS: Three alginate solutions from low (30-50 kDa, VLVG), medium (100 kDa, LVG54) and high (150 kDa, LVG150) molecular weights were examined. Mice were orally administered with the alginate solution before, with and after APAP administration and were compared to control mice which received vehicle only. All mice were euthanized 24 h after APAP administration. Liver enzyme, blood APAP, IL-6 and liver histology including Ki-67 proliferation, IgG necrosis and nitrotyrosine staining were studied.
RESULTS: VLVG- treated mice presented low ALT levels while 20-40 fold increase was demonstrated in control mice. The effect of LVG solutions was marginal. Accordingly, liver histology was normal with no hepatocytes proliferation in the VLVG group while massive centrilobular necrosis, increased nitrotyrosine staining and high proliferation appeared in livers of control mice. APAP blood levels were comparable in the two groups. Treatment with VLVG was associated with prevention of increase of IL-6 serum levels.
CONCLUSION: VLVG, a novel alginate solution, alleviated the liver toxicity and inhibited oncotic necrosis and related immune-mediated damage. VLVG may serve as a novel hepato-protector and prevent drug induced liver injury.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetaminophen; Alginate; Diffusion coefficient; Hepato-protection; Interleukin-6; Liver

Mesh:

Substances:

Year:  2018        PMID: 30468816     DOI: 10.1016/j.taap.2018.11.008

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  4 in total

1.  Smilax china L. Polysaccharide Alleviates Oxidative Stress and Protects From Acetaminophen-Induced Hepatotoxicity via Activating the Nrf2-ARE Pathway.

Authors:  Kaiping Wang; Linlin Yang; Jing Zhou; Xianglin Pan; Zihao He; Junxi Liu; Yu Zhang
Journal:  Front Pharmacol       Date:  2022-04-29       Impact factor: 5.988

Review 2.  Novel Therapies for the Treatment of Drug-Induced Liver Injury: A Systematic Review.

Authors:  Mirjana Stanić Benić; Lana Nežić; Vesna Vujić-Aleksić; Liliana Mititelu-Tartau
Journal:  Front Pharmacol       Date:  2022-02-02       Impact factor: 5.810

3.  A feasibility study using sodium alginate injection for penetrating abdominal trauma in a swine model.

Authors:  Daniel Barsky; Ami Ben Ya'acov; Linn Wagnert Avraham; Dean Nachman; Arik Eisenkraft; Yoav Mintz; Eyal Shteyer
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996

Review 4.  Algae-derived hydrocolloids in foods: applications and health-related issues.

Authors:  Yu-Chen Liao; Chia-Che Chang; Dillirani Nagarajan; Chun-Yen Chen; Jo-Shu Chang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.